4.7 Article

Dominant-negative Hsp90 reduces VEGF-stimulated nitric oxide release and migration in endothelial cells

期刊

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/ATVBAHA.107.155499

关键词

Hsp90; ATP-binding; Akt; migration; dominant-negative

资金

  1. NHLBI NIH HHS [N01-HV-28186, HL64793, P01 HL 70295, R01 HL 57665, R01 HL 61371] Funding Source: Medline
  2. DIVISION OF HEART AND VASCULAR DISEASES [N01HV028186] Funding Source: NIH RePORTER
  3. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064793, R01HL061371, R01HL057665, P01HL070295] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Objectives-Heat-shock protein 90 (Hsp90) coordinates the regulation of diverse signaling proteins. We try to develop a new tool to explore the regulatory functions of Hsp90 in endothelial cells (ECs) instead of the existing chemical approaches. Methods and Results-We designed a dominant-negative Hsp90 construct by site-direct mutagenesis of residue Asp-88 to Asn (D88N-Hsp90) based on the structure of the ATP/ADP-binding site. Recombinant wild-type Hsp90 protein binds ATP-Sepharose beads in manner inhibited by ATP or 17-AAG, a specific inhibitor for Hsp90, however the binding activity of D88N-Hsp90 was markedly reduced and the inhibitory effects of ATP or 17-AAG were negligible. The dimerization between endogenous Hsp90 alpha and exogenous HA-Hsp90 beta was confirmed by immunoprecipitation, however the association between eNOS and D88N-Hsp90 was less than WT-Hsp90. Furthermore, adenoviral transduction of bovine aortic ECs with D88N-Hsp90 suppressed VEGF-induced phosphorylation of Akt, eNOS, and NO release and the inhibitory effect was blocked by okadaic acid. Moreover, D88N-Hsp90 abolished VEGF-stimulated Rac activation and suppressed VEGF-induced stress fiber formation. Transduction with D88N-Hsp90 decreased growth medium mediated migration of wild-type ECs, but not Akt1(-/-) ECs suggesting that Akt is key target of Hsp90. Conclusions-Our data demonstrate that dominant-negative Hsp90 modulates endothelial cell mobility mainly through PP2A-mediated dephosphorylation of Akt and Rac activation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, Research & Experimental

NOGOB receptor mediated RAS signaling pathway is a target for suppressing proliferating hemangioma

Wenquan Hu, Zhong Liu, Valerie Salato, Paula E. North, Joyce Bischoff, Suresh N. Kumar, Zhi Fang, Sujith Rajan, M. Mahmood Hussain, Qing R. Miao

Summary: Infantile hemangioma is characterized by rapid growth and slow involution of disorganized blood vessels. NGBR was found to be highly expressed in the proliferating phase of hemangioma but decreased in the involuting phase. Knockdown of NGBR in HemSCs attenuated RAS activation and inhibited cell migration and proliferation, suggesting its role in controlling growth and differentiation of hemangioma stem cells.

JCI INSIGHT (2021)

Article Genetics & Heredity

Progressive myoclonus epilepsies-Residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genes

Carolina Courage, Karen L. Oliver, Eon Joo Park, Jillian M. Cameron, Kariona A. Grabinska, Mikko Muona, Laura Canafoglia, Antonio Gambardella, Edith Said, Zaid Afawi, Betul Baykan, Christian Brandt, Carlo di Bonaventura, Hui Bein Chew, Chiara Criscuolo, Leanne M. Dibbens, Barbara Castellotti, Patrizia Riguzzi, Angelo Labate, Alessandro Filla, Anna T. Giallonardo, Geza Berecki, Christopher B. Jackson, Tarja Joensuu, John A. Damiano, Sara Kivity, Amos Korczyn, Aarno Palotie, Pasquale Striano, Davide Uccellini, Loretta Giuliano, Eva Andermann, Ingrid E. Scheffer, Roberto Michelucci, Melanie Bahlo, Silvana Franceschetti, William C. Sessa, Samuel F. Berkovic, Anna-Elina Lehesjoki

Summary: Progressive myoclonus epilepsies (PMEs) are a group of clinically and genetically heterogeneous rare diseases, with over 70% of cases now molecularly solved. By performing whole-exome sequencing on unsolved PME-affected individuals, novel disease-causing variants were identified, particularly in cases studied with additional family members. A variety of new genes related to lysosomal and endosomal function were discovered, shedding light on the genetic complexity of PME.

AMERICAN JOURNAL OF HUMAN GENETICS (2021)

Article Biology

eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin

Takeshi Ninchoji, Dominic T. Love, Ross O. Smith, Marie Hedlund, Dietmar Vestweber, William C. Sessa, Lena Claesson-Welsh

Summary: In this study, suppression of nitric oxide formation resulted in reduced retinal neoangiogenesis and decreased vascular leakage through stabilized endothelial adherens junctions. This has important implications for preventing vascular leakage in ocular diseases.
Article Ophthalmology

Characterization of a Novel Caveolin Modulator That Reduces Vascular Permeability and Ocular Inflammation

Pascal N. Bernatchez, Bo Tao, Ralph A. Bradshaw, David Eveleth, William C. Sessa

Summary: The study aimed to identify a novel CPP for improved delivery of a truncated Cav modulator. Results showed that fusion with peptide RRPPR efficiently blocked NO release and VEGF-induced permeability, reducing immune-mediated retinal damage.

TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Defective Flow-Migration Coupling Causes Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia

Hyojin Park, Jessica Furtado, Mathilde Poulet, Minhwan Chung, Sanguk Yun, Sungwoon Lee, William C. Sessa, Claudio A. Franco, Martin A. Schwartz, Anne Eichmann

Summary: This study demonstrates the critical role of ALK1 in controlling endothelial cell polarization against blood flow direction and promoting vein-to-artery migration, while identifying integrin-YAP/TAZ signaling blockers as potential targets for preventing vascular malformations in patients with hereditary hemorrhagic telangiectasia.

CIRCULATION (2021)

Article Biology

Inflammatory stress signaling via NF-kB alters accessible cholesterol to upregulate SREBP2 transcriptional activity in endothelial cells

Joseph Wayne M. Fowler, Rong Zhang, Bo Tao, Nabil E. Boutagy, William C. Sessa

Summary: The relationship between cholesterol homeostasis and immunity in leukocytes has been extensively studied, but not much is known about this relationship in vascular endothelium cells. This study reveals the role of cholesterol and the transcription regulator SREBP2 in the inflammatory response of endothelial cells.
Article Biotechnology & Applied Microbiology

Nogo-B receptor increases glycolysis and the paclitaxel resistance of estrogen receptor-positive breast cancer via the HIF-1α-dependent pathway

Chang Liu, Sijie Li, Xiaoxiao Zhang, Chunxiang Jin, Baofeng Zhao, Liying Li, Qing Robert Miao, Ying Jin, Zhimin Fan

Summary: NgBR plays a role in regulating metabolism and paclitaxel resistance in breast cancer, and may be a new therapeutic target for improving chemoresistance in ER-positive breast cancer.

CANCER GENE THERAPY (2023)

Correction Biotechnology & Applied Microbiology

Nogo-B receptor increases glycolysis and the paclitaxel resistance of estrogen receptor-positive breast cancer via the HIF-1α-dependent pathway (Oct, 10.1038/s41417-022-00553-3, 2022)

Chang Liu, Sijie Li, Xiaoxiao Zhang, Chunxiang Jin, Baofeng Zhao, Liying Li, Qing Robert Miao, Ying Jin, Zhimin Fan

CANCER GENE THERAPY (2023)

Article Biochemistry & Molecular Biology

SREBP2 regulates the endothelial response to cytokines via direct transcriptional activation of KLF6

Joseph Wayne M. Fowler, Nabil E. Boutagy, Rong Zhang, Daiki Horikami, Michael B. Whalen, Casey E. Romanoski, William C. Sessa

Summary: The transcription factor SREBP2 is the main regulator of cholesterol homeostasis and has been implicated in leukocyte immune responses. In this study, the role of SREBP2 in endothelial cells was investigated, revealing its impact on inflammatory chemokine production and interferon response genes.

JOURNAL OF LIPID RESEARCH (2023)

Article Multidisciplinary Sciences

An optogenetic-phosphoproteomic study reveals dynamic Akt1 signaling profiles in endothelial cells

Wenping Zhou, Wenxue Li, Shisheng Wang, Barbora Salovska, Zhenyi Hu, Bo Tao, Yi Di, Ujwal Punyamurtula, Benjamin E. E. Turk, William C. C. Sessa, Yansheng Liu

Summary: The authors used optogenetics and mass spectrometry-based phosphoproteomics to study the effects of different intensities, durations, and patterns of Akt1 activation on phosphorylation circuits, revealing downstream signaling outcomes of Akt1. The study showed that different intensities, durations, and patterns of Akt1 activation lead to distinct phosphorylation profiles in vascular endothelial cells, and also revealed the interaction between Akt1 signaling and growth factor signaling in these cells. The resulting dataset provides an important resource for future studies on AKT signaling and dynamics.

NATURE COMMUNICATIONS (2023)

Review Gastroenterology & Hepatology

Molecular determinants of peri-apical targeting of inositol 1,4,5-trisphosphate receptor type 3 in cholangiocytes

Michele A. Rodrigues, Dawidson A. Gomes, Romina Fiorotto, Mateus T. Guerra, Jittima Weerachayaphorn, Tao Bo, William C. Sessa, Mario Strazzabosco, Michael H. Nathanson

Summary: Fluid and bicarbonate secretion in cholangiocytes is regulated by ITPR3, which localizes to the apical region. This localization is dependent on intact lipid rafts and interactions with CAV1 and MYH9. Disruption of lipid rafts or knockdown of CAV1 or MYH9 impairs ITPR3 localization and secretion.

HEPATOLOGY COMMUNICATIONS (2022)

Article Medicine, Research & Experimental

NOGOB receptor deficiency increases cerebrovascular permeability and hemorrhage via impairing histone acetylation-mediated CCM1/2 expression

Zhi Fang, Xiaoran Sun, Xiang Wang, Ji Ma, Thomas Palaia, Ujala Rana, Benjamin Miao, Louis Ragolia, Wenquan Hu, Qing Robert Miao

Summary: The loss of cerebral cavernous malformation (CCM) genes leads to vascular lesions in the brain. This study reveals that genetic depletion of the NOGOB receptor (NGBR) in endothelial cells (ECs) results in CCM1/2 expression deficiency and cerebrovascular lesions. Mechanistically, NGBR is required for maintaining the expression of CCM1/2 in ECs through HBO1-mediated histone acetylation.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Review Medicine, Research & Experimental

Targeting the vasculature in cardiometabolic disease

Nabil E. Boutagy, Abhishek K. Singh, William C. Sessa

Summary: Obesity is a major contributor to insulin resistance and type 2 diabetes, increasing the risk of cardiovascular disease. Metabolic changes caused by obesity negatively affect the vasculature, exacerbating disease progression. Understanding the cellular and molecular processes is crucial for optimizing medical therapies.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Medicine, Research & Experimental

Eruptive xanthoma model reveals endothelial cells internalize and metabolize chylomicrons, leading to extravascular triglyceride accumulation

Ainara G. Cabodevilla, Songtao Tang, Sungwoon Lee, Adam E. Mullick, Jose O. Aleman, M. Mahmood Hussain, William C. Sessa, Nada A. Abumrad, Ira J. Goldberg

Summary: Despite the primary role of LpL in tissue uptake of fatty acids from chylomicrons, studies have shown that an additional pathway exists for transferring dietary lipids to tissues. This pathway involves endothelial cell uptake of chylomicrons, hydrolysis in lysosomes, and subsequent lipid accumulation in cells. Competing with HDL and targeting the scavenger receptor-BI can inhibit this process in vivo, potentially reducing lipid accumulation in tissues and preventing conditions such as eruptive xanthomas.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Cell Biology

Pazopanib ameliorates acute lung injuries via inhibition of MAP3K2 and MAP3K3

Qianying Yuan, Abdul Basit, Wenhua Liang, Rihao Qu, Yi Luan, Chunguang Ren, Ao Li, Xin Xu, Xiaoqing Liu, Chun Yang, Andrew Kuo, Richard Pierce, Longbo Zhang, Benjamin Turk, Xin Hu, Fangyong Li, Weixue Cui, Run Li, Danxia Huang, Lili Mo, William C. Sessa, Patty J. Lee, Yuval Kluger, Bing Su, Wenwen Tang, Jianxing He, Dianqing Wu

Summary: Pazopanib ameliorates ALI manifestations by inhibiting the phosphorylation of NADPH oxidase 2 subunit p47(phox) through MAP3K2 and MAP3K3. This drug also reduces edema in human lung transplantation recipients, indicating potential for treating ALI.

SCIENCE TRANSLATIONAL MEDICINE (2021)

暂无数据